BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6260347)

  • 1. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors.
    Navickis RJ; Shimkin MB; Hsueh AJ
    Cancer Res; 1981 May; 41(5):1646-51. PubMed ID: 6260347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia.
    Juriansz RL; Huseby RA; Wilcox RB
    Cancer Res; 1988 Jan; 48(1):14-8. PubMed ID: 3334987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors.
    Sato B; Spomer W; Huseby RA; Samuels LT
    Endocrinology; 1979 Mar; 104(3):822-31. PubMed ID: 436739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
    Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in fine structure accompanying estrogen-induced tumorigenesis of Leydig cells in the mouse testis.
    Kurland G; Christensen AK; Huseby RA
    Cancer Res; 1975 Jul; 35(7):1671-86. PubMed ID: 236824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteinizing hormone receptor-mediated effects on initiation of spermatogenesis in gonadotropin-deficient (hpg) mice are replicated by testosterone.
    Spaliviero JA; Jimenez M; Allan CM; Handelsman DJ
    Biol Reprod; 2004 Jan; 70(1):32-8. PubMed ID: 12954730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effect of luteinizing hormone on the development and maintenance of 5 alpha-reduced steroid-producing testicular interstitial cell tumors in Fischer 344 rats.
    Chatani F; Nonoyama T; Sudo K; Miyajima H; Takeyama M; Takatsuka D; Mori H; Matsumoto K
    Anticancer Res; 1990; 10(2A):337-42. PubMed ID: 2189360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of continuous testosterone exposure on spontaneous and cadmium-induced tumors in the male Fischer (F344/NCr) rat: loss of testicular response.
    Waalkes MP; Rehm S; Devor DE
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):40-6. PubMed ID: 9007032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dormancy versus extinction of mouse Leydig cell tumors following endocrine-induced regression.
    Huseby RA
    Cancer Res; 1983 Nov; 43(11):5365-78. PubMed ID: 6616470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA synthesis and DNA polymerase activity in Leydig cells of diethylstilbestrol-stimulated mouse testes.
    Spruance SL; Wilcox B; Richards OC; Foster DN; Huseby RA; Samuels LT
    Cancer Res; 1978 Feb; 38(2):424-30. PubMed ID: 620411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice.
    Huseby RA; Page RH
    Cancer Res; 1982 Nov; 42(11):4332-8. PubMed ID: 6751521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells.
    Dirami G; Cooke BA
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):393-401. PubMed ID: 9653071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone receptors and testosterone production in whole testes and purified Leydig cells from the mouse: differences among inbred strains.
    Stalvey JR; Payne AH
    Endocrinology; 1983 May; 112(5):1696-701. PubMed ID: 6299705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative changes in estrogen receptor produced by chronic DES treatment of two mouse strains differing in susceptibility to Leydig cell tumor induction.
    Terakawa N; Huseby RA; Fang SM; Samuels LT
    J Steroid Biochem; 1982 May; 16(5):643-52. PubMed ID: 7201547
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats.
    Cook JC; Mullin LS; Frame SR; Biegel LB
    Toxicol Appl Pharmacol; 1993 Apr; 119(2):195-204. PubMed ID: 8480329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary control of proliferation and differentiation of Leydig cells and their putative precursors in immature hypophysectomized rat testis.
    Dombrowicz D; Sente B; Reiter E; Closset J; Hennen G
    J Androl; 1996; 17(6):639-50. PubMed ID: 9016394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time- and dose-related effects of estradiol and diethylstilbestrol on the morphology and function of the fetal rat testis in culture.
    Lassurguère J; Livera G; Habert R; Jégou B
    Toxicol Sci; 2003 May; 73(1):160-9. PubMed ID: 12657744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species-specific mechanism in rat Leydig cell tumorigenesis by procymidone.
    Murakami M; Hosokawa S; Yamada T; Harakawa M; Ito M; Koyama Y; Kimura J; Yoshitake A; Yamada H
    Toxicol Appl Pharmacol; 1995 Apr; 131(2):244-52. PubMed ID: 7716766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse.
    Huseby RA
    Cancer Res; 1980 Apr; 40(4):1006-13. PubMed ID: 7357531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.